BrainEye key facts
as of Oct 2026- Developer of an eye movement tracking application designed to track neurological health using a smartphone.
- BrainEye is valued at approximately $41.0M as of Oct 2026 (last reported valuation).
- It has raised $5.3M; the latest was Later Stage VC ($5.3M) in Jul 2025.
- Notable investors include ANDHealth, XV Capital.
- Status: Privately Held (backing).
BrainEye's last reported valuation, Jul 2025. Nothing priced has surfaced since.
- ·Watch BrainEye: the Monday email on marks, rounds and moves
BrainEye funding rounds
No funding rounds for BrainEye are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs BrainEye
2BrainEye valuation
BrainEye's last reported valuation was $41 million in Jul 2025. No priced round, secondary trade or fund mark has surfaced since.
BrainEye investors
2 investors are on record for BrainEye, including ANDHealth and XV Capital.
About BrainEye
Developer of an eye movement tracking application designed to track neurological health using a smartphone. The company's brain health assessment technology offers an accessible and reliable tool for detecting brain abnormalities, enabling individuals to monitor and improve their brain health, thereby enhancing overall well-being and performance, while reducing the burden on healthcare systems.
- Sector
- Healthcare
- HQ
- Chippendale, Australia
- Founded
- 2014
- Employees
- 26
- Website
- braineye.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.